Liang Di, Shi Jin, Li Daojuan, Wu Siqi, Jin Jing, He Yutong
Cancer Institute in Hebei Province, The Fourth Hospital of Hebei Medical University, Shijiazhuang, China.
Front Oncol. 2022 Jan 10;11:795528. doi: 10.3389/fonc.2021.795528. eCollection 2021.
Lung cancer screening has been widely conducted in Western countries. However, population-based lung cancer screening programs in Hebei in China are sparse. Our study aimed to assess the participation rate and detection rate of positive nodules and lung cancer in Hebei province.
In total, 228 891 eligible participants aged 40-74 years were enrolled in the Cancer Screening Program in Hebei from 2013 to 2019. A total of 54 846 participants were evaluated as the lung cancer high-risk population by a risk score system which basically followed the Harvard Risk Index and was adjusted for the characteristics of the Chinese population. Then this high-risk population was recommended for low-dose computed tomography (LDCT) screening. And all participants attended annual passive follow-up, and the active follow-up interval was based on radiologist's suggestion. All participants were followed-up until December 31, 2020. The overall, group-specific participation rates were calculated, and its associated factors were analyzed by a multivariable logistic regression model. Participation rates and detection of positive nodules and lung cancer were reported.
The overall participation rate was 52.69%, where 28 899 participants undertook LDCT screening as recommended. The multivariable logistic regression model demonstrated that a high level of education, having disease history, and occupational exposure were found to be associated with the participation in LDCT screening. The median follow-up time was 3.56 person-years. Overall, the positive identification of lung nodules and suspected lung cancer were 12.73% and 1.46% through LDCT screening. After the native and passive follow-up, 257 lung cancer cases were diagnosed by lung cancer screening, and the detection rate of lung cancer was 0.89% in the screening group. And its incidence density was 298.72 per 100,000. Positive lung nodule rate and detection rate were increased with age.
Our study identified personal and epidemiological factors that could affect the participation rate. Our findings could provide the guideline for precise prevention and control of lung cancer in the future.
肺癌筛查在西方国家已广泛开展。然而,中国河北省基于人群的肺癌筛查项目较少。我们的研究旨在评估河北省阳性结节和肺癌的参与率及检出率。
2013年至2019年,共有228891名年龄在40 - 74岁的符合条件的参与者纳入河北省癌症筛查项目。共有54846名参与者通过一个基本遵循哈佛风险指数并根据中国人群特征进行调整的风险评分系统被评估为肺癌高危人群。然后建议该高危人群进行低剂量计算机断层扫描(LDCT)筛查。所有参与者接受年度被动随访,主动随访间隔根据放射科医生的建议确定。所有参与者随访至2020年12月31日。计算总体及特定组别的参与率,并通过多变量逻辑回归模型分析其相关因素。报告阳性结节和肺癌的参与率及检出情况。
总体参与率为52.69%,其中28899名参与者按建议进行了LDCT筛查。多变量逻辑回归模型显示,受教育程度高、有病史和职业暴露与参与LDCT筛查有关。中位随访时间为3.56人年。总体而言,通过LDCT筛查,肺结节和疑似肺癌的阳性识别率分别为12.73%和1.46%。经过主动和被动随访,通过肺癌筛查确诊257例肺癌病例,筛查组肺癌检出率为0.89%。其发病密度为每10万人298.72例。肺结节阳性率和检出率随年龄增加而升高。
我们的研究确定了可能影响参与率的个人和流行病学因素。我们的研究结果可为未来肺癌的精准防控提供指导。